Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Sublingual tizanidine 12 mg | [1] Tizanidine Tizanidine (Mylan-tizanidine) | [1] Tizanidine
Tizanidine
(Tizanidine) 💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 2 | Tizanidine | [1] Tizanidine Tizanidine (Mylan-tizanidine) | [1] Tizanidine
Tizanidine
(Tizanidine) 💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 3 | Tizanidine (sublingual or oral) | [1] Tizanidine Tizanidine (Mylan-tizanidine) | [1] Tizanidine
Tizanidine
(Tizanidine) 💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 4 | Tizanidine hydrochloride capsule | [1] Tizanidine Tizanidine (Mylan-tizanidine) | [1] Tizanidine
Tizanidine
(Tizanidine) 💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|